Updated advice to be given by Triple Zero call-takers is being developed
In May 2012, Australia’s first take-home naloxone program for opioid overdose prevention commenced in the Australian Capital Territory1; it was soon followed by programs in other jurisdictions. Current Australian naloxone training programs cover calling an ambulance, administering naloxone and giving cardiopulmonary resuscitation (CPR). Some training programs are as short as 10 minutes, and others are as long as 2 hours, so capacity to present practical emergency management scenarios, including calls to emergency services, varies.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Lenton S, Dietze P, Olsen A, et al. Working together: expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond. Drug Alcohol Rev 2014; 34: 404-411.
- 2. Community Overdose Prevention and Education. Recognising opioid overdose. http://www.copeaustralia.com.au/overdose/recognising-opioid-overdose (accessed Jan 2016).
- 3. Idris AH, Guffey D, Aufderheide TP, et al. Relationship between chest compression rates and outcomes from cardiac arrest. Circulation 2012; 125: 3004-3012.
- 4. Sell RE, Sarno R, Lawrence B, et al. Minimizing pre- and post-defibrillation pauses increases the likelihood of return of spontaneous circulation (ROSC). Resuscitation 2010; 81: 822-825.
- 5. Bobrow BJ, Clark LL, Ewy GA, et al. Minimally interrupted cardiac resuscitation by emergency medical services for out-of-hospital cardiac arrest. JAMA 2008; 299: 1158-1165.
- 6. Christenson J, Andrusiek D, Everson-Stewart S, et al. Chest compression fraction determines survival in patients with out-of-hospital ventricular fibrillation. Circulation 2009; 120: 1241-1247.
- 7. Olsen A, McDonald D, Lenton S, Dietze P. Implementing expanded naloxone availability in the ACT (I-ENAACT) Program. Canberra: ACT Health, 2015.
- 8. Darke S, Ross J, Hall W. Overdose among heroin users in Sydney, Australia: II. responses to overdose. Addiction 1996; 91: 413-417.
- 9. Banjo O, Tzemis D, Al-Qutub D, et al. A quantitative and qualitative evaluation of the British Columbia Take Home Naloxone program. CMAJ Open 2014; 2: E153-E161.
- 10. Lankenau SE, Wagner KD, Silva K, et al. Injection drug users trained by overdose prevention programs: responses to witnessed overdoses. J Community Health 2013; 38: 133-141.
- 11. Davidson PJ, Ochoa KC, Hahn JA, et al. Witnessing heroin-related overdoses: the experiences of young injectors in San Francisco. Addiction 2002; 97: 1511-1516.
- 12. Harm Reduction Victoria. Naloxone update 05. http://hrvic.org.au/overdose/naloxone-update (accessed Jun 2015).
We thank the members of the NNRG who contributed to this article. The NNRG is run under the auspices of the Centre for Research Excellence into Injecting Drug Use (National Health and Medical Research Council [NHMRC] grant number 1001144). This work was supported by the Victorian Operational Infrastructure Support Program, which provides funding to the Burnet Institute. Kate Cantwell was funded by an NHMRC Postgraduate Scholarship and Paul Dietze is funded by an NHMRC Senior Research Fellowship.
Ingrid van Beek is involved in the delivery of a take-home naloxone program. Paul Dietze has been the recipient of an untied educational grant from Reckitt Benckiser.